Clinical trials
Hypertension trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 10 |
| Unknown status | 4 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 20 |
| The University of Hong Kong | 11 |
| Boehringer Ingelheim | 4 |
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| The Hong Kong Polytechnic University | 2 |
| CSL Behring | 1 |
| Education University of Hong Kong | 1 |
| Hong Kong Metropolitan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 53 |
| Diabetes Mellitus | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Cardiovascular Diseases | 4 |
| Hyperlipidemias | 3 |
| Renal Insufficiency, Chronic | 3 |
| Stroke | 3 |
| Cerebral Hemorrhage | 2 |
| Dyslipidemias | 2 |
| Essential Hypertension | 2 |
Trials
Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.